Wearable Devices and Biomarkers Project (Healthiomics)
Study of Clinical Biomarkers in Human Health and Disease (Healthiomics)
CureScience
3,500 participants
Oct 11, 2021
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to collect clinical data, biological specimens (e.g., blood, tumor, cerebrospinal fluid, urine sample, etc.), and digital health data from patients with tumors, cancer and/or neurological disorders in order to perform research studies that could advance patient care. By collecting these specimens, the investigators plan to create and maintain a biorepository to make data and specimens available to collaborating investigators performing research to discover predictive biomarkers, patterns of care, and personalized treatments that could directly improve the care of our patients through focused proof-of-concept clinical trials.
Eligibility
Inclusion Criteria7
- Participant or participant's legally authorized representative has the ability to understand and the willingness to provide a signed and dated informed consent form.
- Participant is ≥ 18 years of age.
- Participant had/has a scheduled appointment with oncology or neurosciences services at the participating medical and surgical facility.
- Participant is characterized by at least one of the following criteria:
- Has a neurological complication from any type of cancer, or is under evaluation for a possible cancer diagnosis or neurologic complication. Participant may be newly diagnosed, in relapse, or be free of disease at the time of recruitment. Participant without a confirmed cancer diagnosis is eligible.; OR
- Has a neurological disorder, or is under evaluation for a possible diagnosis of a neurological disorder; OR
- Does not meet the characteristic of either a. or b. above. This participant would be considered a "healthy control" for cancer and neurological disorders.
Exclusion Criteria1
- Participant or participant's legally authorized representative is unable to provide informed consent.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05106725